Please Wait.....
Report
Australia Veterinary Healthcare - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026 - 2031)
Market Report I 2026-02-09 I 78 Pages I Mordor Intelligence
Australia Veterinary Healthcare Market Analysis
The Australia veterinary healthcare market was valued at USD 1.09 billion in 2025 and estimated to grow from USD 1.17 billion in 2026 to reach USD 1.66 billion by 2031, at a CAGR of 7.26% during the forecast period (2026-2031). The current market size reflects sustained expenditure growth on animal health products and services, while the projected CAGR highlights the resilience of the Australia veterinary healthcare market despite workforce and cost pressures. Key momentum builders include a triple-digit surge in annual pet spending, rising biosecurity outlays, and expanding livestock exports that collectively widen the revenue base for therapeutics, diagnostics, and ancillary services. Consolidation among corporate practice groups is reshaping competitive intensity, and technology adoption-most notably AI-enabled diagnostics-is shortening decision times and creating new service lines. Government funding for novel vaccines, alongside insurance penetration gains, underpins both preventive care adoption and market opportunity recognition across urban and rural settings.
Australia Veterinary Healthcare Market Trends and Insights
Rising Animal Health Expenditure
Annual pet outlays have soared to USD 33 billion, nearly triple 2019 levels, confirming a deepening human-animal bond that supports premium medical, surgical, and preventive services. Owners increasingly authorize procedures that cost over USD 10,000, prompting clinic investment in advanced equipment and specialty staffing. This spending reliability encourages capital allocation toward imaging suites, endoscopy units, and regenerative therapies. Parallel growth in insurance enrollment improves affordability for high-ticket interventions and balances clinic revenue cycles. The Australia veterinary healthcare market therefore benefits from recurrent, diversified spend streams that raise baseline demand.
Growth In Livestock Export Industry
Livestock exports generate USD 67 billion per year and sustain 428,000 jobs, compelling producers to engage veterinarians for continuous surveillance, certification, and emergency preparedness. Fear of foot-and-mouth disease, with modeled losses of USD 80 billion, elevates the value placed on vaccination and diagnostic regimes. Breakthroughs in mRNA vaccine research position Australia as both a user and supplier of novel biologics, adding an exportable pharmaceutical dimension to the Australia veterinary healthcare market.
High Cost of Veterinary Services
Clinic prices climb more than 8% per year, driven by equipment amortization, compliance overhead, and staff retention costs. Budget-constrained owners delay care, weakening preventive uptake and shifting volume toward emergency interventions. Overdiagnosis narratives in mainstream media erode trust and intensify price sensitivity. This pressure caps upside in some localities of the Australia veterinary healthcare market even as aggregate spend rises.
Other drivers and restraints analyzed in the detailed report include:
Increasing Pet Ownership & UrbanizationAdvancements In Veterinary TechnologiesShortage Of Skilled Veterinary Workforce
For complete list of drivers and restraints, kindly check the Table Of Contents.
Segment Analysis
Therapeutics contributed 60.58% to 2025 revenue as vaccines, parasiticides, and anti-infectives formed the backbone of clinical interventions. Government funding for avian influenza preparedness and world-first livestock mRNA projects boosts vaccine demand. Parasiticide uptake remains robust due to outdoor pet lifestyles, and antimicrobial stewardship programs guide prudent anti-infective use. In contrast, diagnostics posted only a modest base in 2025 yet display a 7.31% CAGR through 2031, signaling a pivot toward early disease recognition and wellness screening. Immunoassay kits dominate the Australia veterinary healthcare market size for diagnostics, and AI image analysis platforms create subscription revenue streams for early adopters. Consequently, therapeutics will maintain volume leadership, but diagnostics will shape margin expansion strategies for providers across the Australia veterinary healthcare market.
Diagnostics growth also stems from practice conversion to POC devices that allow same-day decision-making and client reassurance. Molecular assays detecting zoonotic agents fit national biosecurity objectives and attract cost-sharing grants. Bundled wellness plans incorporating annual screening lock in client loyalty and stabilize cash flow. Together, these dynamics illustrate how preventive paradigms are remolding product mix in the Australia veterinary healthcare market.
Dogs and cats secured a 44.28% share in 2025, benefiting from urban humanization trends and growing insurance coverage that finances complex care regimens. Specialty services such as oncology and orthopedics push average transaction values higher. Nonetheless, poultry registers the quickest growth at an 8.21% CAGR, tied to export expansion and strict international health standards. Avian producers require continuous surveillance, vaccination, and certification, channeling revenue toward biologics and diagnostics. The Australia veterinary healthcare market share for livestock overall rises as producers preempt economic shock from disease outbreaks.
Equine medicine retains a high-value niche linked to racing, while aquaculture opens incremental upside through vaccine innovation targeting Iridoviridae. Sheep and goats remain underserved, offering white-space potential for practices developing small-ruminant expertise. Broadly, companion animal volume sustains core demand, and poultry ensures incremental lift, maintaining balance in the Australia veterinary healthcare market.
The Australia Veterinary Healthcare Market Report is Segmented by Product (Therapeutics, Diagnostics, Veterinary Services), Animal Type (Companion Animals, Livestock Animals), Route of Administration (Parenteral, Oral), End User (Veterinary Hospitals, Veterinary Clinics, Retail Pharmacies, E-Commerce, On-Farm Delivery), and Geography. The Market Forecasts are Provided in Terms of Value (USD).
List of Companies Covered in this Report:
Zoetis MSD Animal Health (Merck & Co.) Elanco Boehringer Ingelheim Virbac Ceva Vetoquinol IDEXX Chemvet Australia Jurox Sypharma Luoda Pharma QBiotics Group Ltd Abbey Animal Health Greencross Ltd Apiam Animal Health Ltd Im3 Pty Ltd Neogen Australasia Henry Schein Animal Health National Veterinary Care (NVC) Delvet Pty Ltd
Additional Benefits:
The market estimate (ME) sheet in Excel format
3 months of analyst support
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Animal Health Expenditure
4.2.2 Growth in Livestock Export Industry
4.2.3 Increasing Pet Ownership & Urbanization
4.2.4 Advancements in Veterinary Technologies
4.2.5 Government Biosecurity Initiatives
4.2.6 Expansion of Pet Insurance Coverage
4.3 Market Restraints
4.3.1 High Cost of Veterinary Services
4.3.2 Stringent Regulatory Approval Processes
4.3.3 Shortage of Skilled Veterinary Workforce
4.3.4 Proliferation of Counterfeit Animal Medicines
4.4 Regulatory Landscape
4.5 Porter's Five Forces Analysis
4.5.1 Threat Of New Entrants
4.5.2 Bargaining Power Of Buyers
4.5.3 Bargaining Power Of Suppliers
4.5.4 Threat Of Substitutes
4.5.5 Intensity Of Competitive Rivalry
5 Market Size & Growth Forecasts (Value, USD)
5.1 By Product
5.1.1 Therapeutics
5.1.1.1 Vaccines
5.1.1.2 Parasiticides
5.1.1.3 Anti-Infectives
5.1.1.4 Medical Feed Additives
5.1.1.5 Other Therapeutics
5.1.2 Diagnostics
5.1.2.1 Immunodiagnostic Tests
5.1.2.2 Molecular Diagnostics
5.1.2.3 Diagnostic Imaging
5.1.2.4 Clinical Chemistry
5.1.2.5 Point-Of-Care Testing Devices
5.2 By Animal Type
5.2.1 Other Diagnostics
5.2.2 Dogs & Cats
5.2.3 Horses
5.2.4 Ruminants
5.2.5 Swine
5.2.6 Poultry
5.2.7 Other Animal Types
5.3 By Route Of Administration
5.3.1 Oral
5.3.2 Parenteral
5.3.3 Topical
5.3.4 Other Route of Administrations
5.4 By End User
5.4.1 Veterinary Hospitals & Clinics
5.4.2 Reference Laboratories
5.4.3 Point-Of-Care / In-House Testing Settings
5.4.4 Academic & Research Institutes
6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share, Products & Services, Recent Developments)
6.3.1 Zoetis Inc.
6.3.2 MSD Animal Health (Merck & Co.)
6.3.3 Elanco Animal Health
6.3.4 Boehringer Ingelheim Animal Health
6.3.5 Virbac
6.3.6 Ceva Animal Health Pty Ltd
6.3.7 Vetoquinol SA
6.3.8 IDEXX Laboratories
6.3.9 Chemvet Australia Pty Ltd
6.3.10 Jurox Pty Ltd
6.3.11 Sypharma Pty Ltd
6.3.12 Luoda Pharma Pty Ltd
6.3.13 QBiotics Group Ltd
6.3.14 Abbey Animal Health Pty Ltd
6.3.15 Greencross Ltd
6.3.16 Apiam Animal Health Ltd
6.3.17 Im3 Pty Ltd
6.3.18 Neogen Australasia
6.3.19 Henry Schein Animal Health
6.3.20 National Veterinary Care (NVC)
6.3.21 Delvet Pty Ltd
7 Market Opportunities & Future Outlook
7.1 White-Space & Unmet-Need Assessment
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security